Advertisement

Sequential coronary bifurcation revascularization with the Xposition S™ self-apposing stent: a comparative fractal bench study

  • François DérimayEmail author
  • Luc Maillard
  • Gilles Rioufol
  • Géraud Souteyrand
  • Adel Aminian
  • Joëlle Veziers
  • Patrice Guerin
  • Gérard Finet
Short Communication
  • 18 Downloads

Abstract

Coronary bifurcation revascularization needs to take account of the diameter differential between vessels and to limit side-branch obstruction (SBO). The self-apposing properties of the Xposition S™ stent (STENTYS, France) seem interesting in this regard. The present experimental fractal bench study determined the best provisional stenting technique using Xposition S™. Three sequential strategies were compared (n = 5/group): implantation alone, side-branch inflation (SBI), and re-POT (initial proximal optimization technique (POT) + SBI + final POT). 2D- and 3D-OCT analyses and micro-CT scan were performed to quantify the main mechanical results at each step. Of the three groups, SBI and re-POT provided better final results than implantation alone in terms of residual SBO (respectively, 24.6 ± 5.6% and 24.8 ± 5.0% vs. 46.5 ± 10.3%, p < 0.05) and malapposition (respectively, 0.9 ± 0.6% and 0.8 ± 0.4% vs. 3.8 ± 1.9%, p < 0.05). Unlike SBI, the two POTs of the re-POT sequence did not improve the final result. SBI, alone or as part of re-POT, systematically led to one connector breakage, whereas implantation alone maintained complete stent integrity (p < 0.05). In Xposition S™ implantation, SBI should be systematic, but not post-dilatation specifically dedicated to bifurcation stenting (i.e., POTs). However, global post-dilatation is still mandatory to prevent stent underexpansion due to untreated stenosis.

Keywords

re-POT Proximal optimization technique Provisional stenting Nitinol stent 

Abbreviations

BES

Balloon-expandable stent

SBI

Side-branch inflation

SBO

Side-branch obstruction

POT

Proximal optimization technique

Notes

Compliance with ethical standards

Conflict of interest

The authors have no relevant relationships to disclose. STENTYS unconditionally provided all stents and a grant to finance the experiments.

References

  1. 1.
    Lassen JF, Burzotta F, Banning AP, Lefèvre T, Darremont O, Hildick-Smith D, Chieffo A, Pan M, Holm NR, Louvard Y, Stankovic G (2018) Percutaneous coronary intervention for the left main stem and other bifurcation lesions. The 12th consensus document from the European Bifurcation Club. EuroIntervention 13(13):1540–1553CrossRefGoogle Scholar
  2. 2.
    Finet G, Dérimay F, Motreff P, Guerin P, Pilet P, Ohayon J, Darremont O, Rioufol G (2015) Comparative Analysis of sequential proximal optimizing technique versus kissing balloon inflation technique in provisional bifurcation stenting: fractal coronary bifurcation bench test. JACC Cardiovasc Interv 8(10):1308–1317CrossRefGoogle Scholar
  3. 3.
    Dérimay F, Souteyrand G, Motreff P, Rioufol G, Finet G (2017) Influence of platform design of six different drug-eluting stents in provisional coronary bifurcation stenting by rePOT sequence: a comparative bench analysis. EuroIntervention 13:e1092–e1095CrossRefGoogle Scholar
  4. 4.
    Dérimay F, Finet G, Souteyrand G, Maillard L, Aminian A, Lattuca B, Cayla G, Cellier G, Motreff P, Rioufol G (2018) Benefit of a new provisional stenting strategy: the re-proximal optimizing technique. The rePOT clinical study. EuroIntervention 14(3):e325–e332CrossRefGoogle Scholar
  5. 5.
    Naber CK, Pyxaras SA, Nef H, Ijsselmuiden AJ, Briguori C, Schlundt C, Wykrzykowska J, Eberli FR, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns RJ, Bouchez D, Mudra H (2016) Final results of a self-apposing paclitaxel-eluting stent for the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study. EuroIntervention 12(3):356–358CrossRefGoogle Scholar
  6. 6.
    Cortese B, Montefusco A, D'Ascenzo F, La Manna A, Andò G, Bisceglia T, Secco GG, Meyer-Gessner M, Wańha W, Sganzerla P, Napodano M, Di Palma G, Latini RA, Tamburino C, Orrego PS, Baumbach A (2018) Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt—the MATISSE study. Cardiovasc Revasc Med 19(7 pt B):831–836CrossRefGoogle Scholar
  7. 7.
    Wańha W, Mielczarek M, Smolka G, Roleder T, Jaguszewski M, Ciećwierz D, Tomasiewicz B, Kubler P, Gorol J, Chmielecki M, Bartuś S, Navarese EP, Kasprzak M, Sukiennik A, Kubica J, Lekston A, Hawranek M, Reczuch K, Gruchała M, Ochała A, Wojakowski W (2019) Safety and efficacy of self-apposing Stentys drug-eluting stent in left main coronary artery PCI: Multicentre LM-STENTYS registry. Catheter Cardiovasc Interv 93(4):574–582CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Cardiology DepartmentCardiovascular Hospital and INSERM U-1060LyonFrance
  2. 2.GCS ES Axium RambotAix-en-ProvenceFrance
  3. 3.Cardiology DepartmentCHU Clermont-FerrandClermont-FerrandFrance
  4. 4.Cardiology DepartmentCHU CharleroiCharleroiBelgium
  5. 5.INSERM UMR 1229NantesFrance
  6. 6.Thorax InstituteNantesFrance
  7. 7.Fédération de Cardiologie MédicaleHôpital Cardiologique Lyon-MonchatLyon Cedex03France

Personalised recommendations